| 506 | 26 | 68 |
| 下载次数 | 被引频次 | 阅读次数 |
目的比较拮抗剂方案与高孕激素状态下促排卵(PPOS)方案在多囊卵巢综合征(PCOS)患者行IVF助孕治疗中的应用效果。方法回顾性分析2016年11月至2017年11月在本院行IVF助孕治疗的138例单纯PCOS不孕症患者的临床资料,根据促排卵方案的不同将患者分为两组:PPOS组(57例)和拮抗剂组(81例)。比较两组患者的一般资料、促排卵情况及胚胎实验室指标。结果两组患者的年龄、月经周期、不孕年限、体重指数(BMI)、基础窦卵泡数、基础FSH、基础LH及基础E2等比较均无显著性差异(P>0.05)。拮抗剂组的Gn总量显著低于PPOS组[(1 725.5±612.9)vs.(2 147.3±811.5)U],早发LH峰发生率(7.4%vs.0%)、直径≥14mm卵泡数[(15.2±8.2)vs.(12.7±7.2)个]、E2峰值[(16 573.7±8 844.7)vs.(12 980.8±7 486.8)pmol/L]、HCG日孕酮(P)水平[(3.15±1.53)vs.(2.68±1.53)nmol/L]、获卵数[(17.2±9.7)vs.(13.0±8.3)个]、轻中度OHSS发生率(6.2%vs.0%)均显著高于PPOS组(P<0.05)。两组间的Gn用药天数、2PN受精率、卵裂率、优质胚胎数、重度OHSS发生率比较均无显著性差异(P>0.05)。结论 PPOS方案能获得与拮抗剂方案相似的优质胚胎数,且能更好地抑制早发LH峰,减少轻中度OHSS发生率,可作为PCOS患者促排卵方案的选择之一。
Abstract：Objective:To compare the IVF efficacy between GnRH antagonist(GnRH-ant)protocol and progestin-primed ovarian stimulation(PPOS)protocol in patients with polycystic ovary syndrome(PCOS).Methods:A retrospective study was performed including 138 PCOS patients undergone IVF treatment in our center from November 2016 to November 2017.Among them,81 cycles were in GnRH-ant protocol group and 57 cycles in PPOS protocol group.The clinical characteristic of patients and the efficacy of the controlled ovarian hyperstimulation(COH)were compared between the two groups.Results:There were no significant differences in age,menstrual cycle,infertility years,body mass index(BMI),number of basal antral follicles,basal levels of FSH,LH and E2 between the two groups(P>0.05).The total amount of gonadotropin(Gn)used [(1 725.5±612.9)vs.(2 147.3±811.5)U],the occurrence of premature LH surge(7.4%vs.0%),the number of follicles with diameter≥14 mm [(15.2±8.2)vs.(12.7±7.2)],the E2 peak level[(16 573.7±8 844.7)vs.(12 980.8±7 486.8)pmol/L],the progesterone level on the HCG day [(3.15±1.53)vs.(2.68±1.53)nmol/L],the number of oocyte retrieved[(17.2±9.7)vs.(13.0±8.3)]and the incidence of mild-to-moderate OHSS(6.2% vs.0%)in GnRH-ant protocol group were significantly higher than those in PPOS protocol group(P<0.05).There was no significant difference in stimulation days,2 PN fertilization rate,cleavage rate,number of good quality embryo,and the incidence of severe OHSS between the two groups.Conclusions:PPOS protocol can obtain similar number of good quality embryos compared with GnRH-ant protocol,and effectively inhibit the premature LH surge and the incidence of mild-to-moderate OHSS.Therefore,PPOS can be used as one of the choices for ovulation induction in patients with PCOS.
[1] March WA,Moore VM,Willson KJ,et al.The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria[J].Hum Reprod,2010,25:544-551.
[2] Al-Inany H,Aboulghar M.GnRH antagonist in assisted reproduction:a Cochrane review[J].Hum Reprod,2002,17:874-885.
[3] Kuang Y,Chen Q,Fu Y,et al.Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization[J].Fertil Steril,2015,104:62-70.
[4] Zhu XX,Zhang XL,Fu YL.Utrogestan as an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization[J].Medicine(Baltimore),2015,94:e909.
[5]杨菁,王艳丹,孙伟,等.高孕激素状态下促排卵与拮抗剂方案应用于卵巢低反应患者的促排卵疗效比较[J].生殖医学杂志,2017,26:791-795.
[6] Zhang J,Mao X,Wang Y,et al.Neonatal outcomes and congenital malformations in children born after human menopausal gonadotropin and medroxyprogesterone acetate treatment cycles[J].Arch Gynecol Obstet,2017,296:1207-1217.
[7] RotterdamESHRE/ASRM-SponsoredPCOSconsensus workshop group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome(PCOS)[J].Hum Reprod,2004,19:41-47.
[8] Rebar R,Judd HL,Yen SS,et al.Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome[J].J Clin Invest,1976,57:1320-1329.
[9] Taylor AE,McCourt B,Martin KA,et al.Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome[J].J Clin Endocrinol Metab,1997,82:2248-2256.
[10] Atkinson P,Koch J,Ledger WL.GnRH agonist trigger and a freeze-all strategy to prevent ovarian hyperstimulation syndrome:a retrospective study of OHSS risk and pregnancy rates[J].Aust N Z J Obstet Gynaecol,2014,54:581-585.
[11]叶红娟,陈秋菊,匡延平.多囊卵巢综合征患者在高孕激素超促排卵中LH与IVF/ICSI临床结局的相关性分析[J].生殖与避孕,2016,36:177-184.
[12]郭丽娜,贾新转,吕翠婷,等.高孕激素状态下促排卵方案用于卵巢正常反应患者IVF-ET的自身对照研究[J].生殖医学杂志,2017,26:127-132.
[13]郭丽娜,晏红伟.孕激素阻断LH峰用于促排卵的方案应用进展[J].生殖医学杂志,2017,26:1057-1061.
[14] Huang CY,Chen GY,Shieh ML,et al.An extremely patientfriendly and efficient stimulation protocol for assisted reproductive technology in normal and high responders[J].Reprod Biol Endocrinol,2018,16:18.
[15] Yu S,Long H,Chang HY,et al.New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF:a randomized controlled trial including 516first IVF/ICSI cycles[J].Hum Reprod,2018,33:229-237.
[16] Lin H,Li Y,Li L,et al.Is a GnRH antagonist protocol better in PCOS patients?A meta-analysis of RCTs[J/OL].PLoS One,2014,9:e91796.
[17] Chen R,Chen S,Liu M,et al.Pregnancy outcomes of PCOS overweight/obese patients after controlled ovarian stimulation with the GnRH antagonist protocol and frozen embryo transfer[J].Reprod Biol Endocrinol,2018,16:36.
基本信息:
中图分类号:R714.8;R711.75
引用信息:
[1]肖卓妮,杨菁,徐望明,等.拮抗剂与高孕激素下促排卵方案用于多囊卵巢综合征患者IVF治疗效果比较[J].生殖医学杂志,2018,27(12):1170-1174.
基金信息:
国家自然科学基金(81471455;81100418)
2018-12-11
2018-12-11